Literature DB >> 18072013

Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men.

K Kerschan-Schindl1, J Wendlova, S Kudlacek, A Gleiss, W Woloszczuk, P Pietschmann.   

Abstract

BACKGROUND: Osteoporosis is one of the most common conditions associated with aging. It is based on an excess of bone resorption over bone formation, leading to an imbalance of bone turnover. The receptor activator of nuclear factor kappaB ligand (RANKL) is an important regulator of bone metabolism.
OBJECTIVE: The aim of this investigation was to evaluate potential age- and gender-related changes in free RANKL and total RANKL (free RANKL+RANKL/osteoprotegerin complexes).
METHODS: Two hundred and forty volunteers with a median age of 48 years were included in the study. Serum levels of free RANKL and total RANKL were evaluated.
RESULTS: On average, men have a 1.77-fold higher free RANKL level and a 2.12-fold higher free/total RANKL ratio than women of the same age. On average, the RANKL levels decrease by approximately 13% every five years.
CONCLUSION: This study showed that serum levels of free RANKL and total RANKL decrease with age, and also revealed some gender-related differences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18072013     DOI: 10.1055/s-2007-993142

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice.

Authors:  S Morony; A P Sage; T Corbin; J Lu; Y Tintut; L L Demer
Journal:  Calcif Tissue Int       Date:  2012-10-09       Impact factor: 4.333

Review 2.  Relationship between serum RANKL and RANKL in bone.

Authors:  D M Findlay; G J Atkins
Journal:  Osteoporos Int       Date:  2011-08-18       Impact factor: 4.507

3.  Age-Related Loss in Bone Mineral Density of Rats Fed Lifelong on a Fish Oil-Based Diet Is Avoided by Coenzyme Q10 Addition.

Authors:  Alfonso Varela-López; Julio J Ochoa; José M Llamas-Elvira; Magdalena López-Frías; Elena Planells; MCarmen Ramirez-Tortosa; Cesar L Ramirez-Tortosa; Francesca Giampieri; Maurizio Battino; José L Quiles
Journal:  Nutrients       Date:  2017-02-22       Impact factor: 5.717

Review 4.  Regulation of TNF-Induced Osteoclast Differentiation.

Authors:  Zhenqiang Yao; Stephen J Getting; Ian C Locke
Journal:  Cells       Date:  2021-12-31       Impact factor: 6.600

5.  Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data.

Authors:  Hui Heng Chua; Sharifah Emilia Tuan Sharif; Wan Faisham Nu'man Wan Ismail; Muhamad Syahrul Fitri Zawawi; Sarimah Abdullah
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

6.  Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.

Authors:  Leonie Neirich; Maryam Yahiaoui-Doktor; Jacqueline Lammert; Maryam Basrai; Benjamin Seethaler; Anika Berling-Ernst; Juliane Ramser; Anne S Quante; Thorsten Schmidt; Uwe Niederberger; Kerstin Rhiem; Rita Schmutzler; Christoph Engel; Stephan C Bischoff; Martin Halle; Marion Kiechle; Sabine Grill
Journal:  Breast Cancer Res Treat       Date:  2021-09-27       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.